{
    "organizations": [],
    "uuid": "dfb7c0c2276432cd1783614a07cfc1ddcb5a646d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-array-biopharma-says-its-partner-s/brief-array-biopharma-says-its-partner-seeks-withdrawal-of-marketing-authorization-applications-for-binimetinib-monotherapy-in-eu-switzerland-and-australia-idUSFWN1PI1BQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Array Biopharma Says Its partner Seeks Withdrawal of Marketing Authorization Applications For Binimetinib Monotherapy in EU, Switzerland And Australia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Array Biopharma Inc:\n* ARRAY BIOPHARMA SAYS PIERRE FABRE MEDICAMENT, REQUESTED THAT MARKETING AUTHORIZATION APPLICATIONS FOR BINIMETINIB MONOTHERAPY BE WITHDRAWN\n* ARRAY BIOPHARMA - WITHDRAWAL OF MAA APPLICATIONS FOR BINIMETINIB MONOTHERAPY IN NRAS-MUTANT MELANOMA REQUESTED IN EU, SWITZERLAND AND AUSTRALIA\n* ARRAY BIOPHARMA - PIERRE FABRE MEDICAMENT IS ARRAY'S COLLABORATION PARTNER Source text: ( bit.ly/2DGm2Ug ) Further company coverage:\n ",
    "published": "2018-01-24T01:01:00.000+02:00",
    "crawled": "2018-01-24T01:16:07.032+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "array",
        "biopharma",
        "inc",
        "array",
        "biopharma",
        "say",
        "pierre",
        "fabre",
        "medicament",
        "requested",
        "marketing",
        "authorization",
        "application",
        "binimetinib",
        "monotherapy",
        "withdrawn",
        "array",
        "biopharma",
        "withdrawal",
        "maa",
        "application",
        "binimetinib",
        "monotherapy",
        "melanoma",
        "requested",
        "eu",
        "switzerland",
        "australia",
        "array",
        "biopharma",
        "pierre",
        "fabre",
        "medicament",
        "array",
        "collaboration",
        "partner",
        "source",
        "text",
        "company",
        "coverage"
    ]
}